IL-17 regulates systemic fungal immunity by controlling the functional competence of NK Cells

Immunity

Volumn 40, Issue 1, 2014, Pages 117-127

  Bär, Eva ^a   Whitney, Paul G ^b   Moor, Kathrin ^a   ReiseSousa, Caetano ^b   LeibundGut Landmann, Salomé ^a  

^a ETH ZURICH   (Switzerland)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CYTOKINE PRODUCTION; FUNGICIDAL ACTIVITY; HISTOLOGY; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENCE; INFECTION; MOUSE; MYCOSIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CANDIDIASIS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-17; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 84892479849     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.12.002     Document Type: Article

References (50)

1. Amulic B., Cazalet C., Hayes G.L., Metzler K.D., Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 2012, 30:459-489.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
3. Bär E., Gladiator A., Bastidas S., Roschitzki B., Acha-Orbea H., Oxenius A., LeibundGut-Landmann S. A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J.Immunol. 2012, 188:5636-5643.
4. Bhatnagar N., Hong H.S., Krishnaswamy J.K., Haghikia A., Behrens G.M., Schmidt R.E., Jacobs R. Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood 2010, 116:1308-1316.
5. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
6. Bouzani M., Ok M., McCormick A., Ebel F., Kurzai O., Morton C.O., Einsele H., Loeffler J. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J.Immunol. 2011, 187:1369-1376.
7. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001, 292:934-937.
8. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
9. Chen K., McAleer J.P., Lin Y., Paterson D.L., Zheng M., Alcorn J.F., Weaver C.T., Kolls J.K. Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 2011, 35:997-1009.
10. Conti H.R., Gaffen S.L. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect. 2010, 12:518-527.
11. Costantini C., Micheletti A., Calzetti F., Perbellini O., Pizzolo G., Cassatella M.A. Neutrophil activation and survival are modulated by interaction with NK cells. Int. Immunol. 2010, 22:827-838.
12. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
13. Cypowyj S., Picard C., Maródi L., Casanova J.L., Puel A. Immunity to infection in IL-17-deficient mice and humans. Eur. J. Immunol. 2012, 42:2246-2254.
14. Degli-Esposti M.A., Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 2005, 5:112-124.
15. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 2006, 24:257-286.
16. Eyerich K., Foerster S., Rombold S., Seidl H.P., Behrendt H., Hofmann H., Ring J., Traidl-Hoffmann C. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J.Invest. Dermatol. 2008, 128:2640-2645.
17. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
18. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 2009, 9:556-567.
19. Ganal S.C., Sanos S.L., Kallfass C., Oberle K., Johner C., Kirschning C., Lienenklaus S., Weiss S., Staeheli P., Aichele P., Diefenbach A. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012, 37:171-186.
20. Gladiator A., Wangler N., Trautwein-Weidner K., LeibundGut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J.Immunol. 2013, 190:521-525.
21. Granucci F., Zanoni I., Pavelka N., Van Dommelen S.L., Andoniou C.E., Belardelli F., Degli Esposti M.A., Ricciardi-Castagnoli P. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J.Exp. Med. 2004, 200:287-295.
22. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J.Immunol. 2006, 176:1517-1524.
23. Hernández-Santos N., Gaffen S.L. Th17 cells in immunity to Candida albicans. Cell Host Microbe 2012, 11:425-435.
24. Höglund P., Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 2010, 10:724-734.
25. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
26. Huang W., Na L., Fidel P.L., Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J.Infect. Dis. 2004, 190:624-631.
27. Hueber W., Sands B.E., Lewitzky S., Vandemeulebroecke M., Reinisch W., Higgins P.D., Wehkamp J., Feagan B.G., Yao M.D., Karczewski M., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012, 61:1693-1700. Secukinumab in Crohn's Disease Study Group.
28. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
29. Kelly M.N., Zheng M., Ruan S., Kolls J., D'Souza A., Shellito J.E. Memory CD4+ Tcells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J.Immunol. 2013, 190:285-295.
30. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
31. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009, 114:357-359.
32. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
33. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., Braun D., Banerjee S. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N.Engl. J. Med. 2012, 366:1190-1199.
34. Lin L., Ibrahim A.S., Xu X., Farber J.M., Avanesian V., Baquir B., Fu Y., French S.W., Edwards J.E., Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009, 5:e1000703.
35. Lionakis M.S., Lim J.K., Lee C.C., Murphy P.M. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J.Innate Immun. 2011, 3:180-199.
36. Loh J., Chu D.T., O'Guin A.K., Yokoyama W.M., Virgin H.W. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J.Virol. 2005, 79:661-667.
37. MacCallum D.M., Castillo L., Brown A.J., Gow N.A., Odds F.C. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS ONE 2009, 4:e6420.
38. Marr K.J., Jones G.J., Zheng C., Huston S.M., Timm-McCann M., Islam A., Berenger B.M., Ma L.L., Wiseman J.C., Mody C.H. Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Infect. Immun. 2009, 77:2436-2446.
39. Martín-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 2004, 5:1260-1265.
40. Maruyama K., Fukasaka M., Vandenbon A., Saitoh T., Kawasaki T., Kondo T., Yokoyama K.K., Kidoya H., Takakura N., Standley D., et al. The transcription factor Jdp2 controls bone homeostasis and antibacterial immunity by regulating osteoclast and neutrophil differentiation. Immunity 2012, 37:1024-1036.
41. Moffitt K.L., Gierahn T.M., Lu Y.J., Gouveia P., Alderson M., Flechtner J.B., Higgins D.E., Malley R. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 2011, 9:158-165.
42. Morandi B., Bougras G., Muller W.A., Ferlazzo G., Münz C. NK cells of human secondary lymphoid tissues enhance Tcell polarization via IFN-gamma secretion. Eur. J. Immunol. 2006, 36:2394-2400.
43. Orange J.S. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002, 4:1545-1558.
44. Ouyang W., Kolls J.K., Zheng Y. The biological functions of Thelper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
45. Papp K.A., Leonardi C., Menter A., Ortonne J.P., Krueger J.G., Kricorian G., Aras G., Li J., Russell C.B., Thompson E.H., Baumgartner S. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N.Engl. J. Med. 2012, 366:1181-1189.
46. Schmidt S., Tramsen L., Hanisch M., Latgé J.P., Huenecke S., Koehl U., Lehrnbecher T. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J.Infect. Dis. 2011, 203:430-435.
47. Sellge G., Magalhaes J.G., Konradt C., Fritz J.H., Salgado-Pabon W., Eberl G., Bandeira A., Di Santo J.P., Sansonetti P.J., Phalipon A. Th17 cells are the dominant Tcell subtype primed by Shigella flexneri mediating protective immunity. J.Immunol. 2010, 184:2076-2085.
48. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
49. Walton S.M., Wyrsch P., Munks M.W., Zimmermann A., Hengel H., Hill A.B., Oxenius A. The dynamics of mouse cytomegalovirus-specific CD4 Tcell responses during acute and latent infection. J.Immunol. 2008, 181:1128-1134.
50. Wüthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., Galles K., Filutowicz H., Warner T., Evans M., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J.Clin. Invest. 2011, 121:554-568.